303,268 Shares in Scholar Rock Holding Corporation $SRRK Bought by Deutsche Bank AG

Deutsche Bank AG bought a new position in shares of Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report) during the 2nd quarter, according to its most recent disclosure with the SEC. The fund bought 303,268 shares of the company's stock, valued at approximately $16,680,000. Deutsche Bank AG owned 0.25% of Scholar Rock at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in SRRK. IFP Advisors Inc boosted its holdings in Scholar Rock by 294.1% in the fourth quarter. IFP Advisors Inc now owns 603 shares of the company's stock valued at $27,000 after acquiring an additional 450 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in Scholar Rock during the 4th quarter valued at approximately $30,000. Summit Securities Group LLC bought a new position in Scholar Rock during the 4th quarter worth approximately $31,000. EverSource Wealth Advisors LLC raised its holdings in Scholar Rock by 151.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 872 shares of the company's stock worth $38,000 after purchasing an additional 525 shares during the last quarter. Finally, Hilton Head Capital Partners LLC acquired a new position in shares of Scholar Rock in the 4th quarter worth approximately $44,000. Institutional investors own 91.08% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on SRRK shares. Citigroup upped their price objective on shares of Scholar Rock from $58.00 to $60.00 and gave the company a "buy" rating in a research note on Friday, August 7th. Barclays lifted their target price on shares of Scholar Rock from $53.00 to $55.00 and gave the stock an "overweight" rating in a research note on Friday, May 8th. Cantor Fitzgerald restated an "overweight" rating on shares of Scholar Rock in a report on Thursday, June 18th. JPMorgan Chase & Co. upped their price target on shares of Scholar Rock from $56.00 to $63.00 and gave the company an "overweight" rating in a research report on Thursday, August 13th. Finally, Wedbush reiterated an "outperform" rating and set a $64.00 price target on shares of Scholar Rock in a report on Friday. Four equities research analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Scholar Rock currently has an average rating of "Buy" and a consensus price target of $58.77.

Scholar Rock Stock Performance

Shares of SRRK stock opened at $56.50 on Friday. The company has a market cap of $6.88 billion, a price-to-earnings ratio of -16.38 and a beta of 0.69. Scholar Rock Holding Corporation has a 52 week low of $27.07 and a 52 week high of $58.49. The company has a quick ratio of 7.02, a current ratio of 7.02 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average of $51.86 and a 200-day moving average of $48.48.

Scholar Rock (NASDAQ:SRRK - Get Free Report) last released its earnings results on Thursday, August 6th. The company reported ($0.84) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.84). During the same quarter last year, the company posted ($0.98) EPS. On average, equities analysts forecast that Scholar Rock Holding Corporation will post -3.23 earnings per share for the current year.

Insider Transactions at Scholar Rock

In other news, Director Joshua Reed sold 3,053 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $53.74, for a total transaction of $164,068.22. Following the transaction, the director owned 19,518 shares of the company's stock, valued at $1,048,897.32. This represents a 13.53% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Katie Peng sold 5,446 shares of the firm's stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $53.88, for a total value of $293,430.48. Following the completion of the sale, the director owned 34,301 shares of the company's stock, valued at approximately $1,848,137.88. This represents a 13.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 17,149 shares of company stock valued at $923,108. 10.30% of the stock is owned by insiders.

Scholar Rock Profile

Scholar Rock is a clinical-stage biotechnology company focused on the discovery and development of protein therapeutics that selectively target growth factors involved in disease processes. The company's research platform is designed to modulate endogenous growth factor activation and signaling with high specificity, aiming to restore normal biological function across a range of disorders. Scholar Rock's approach is distinguished by its emphasis on engineering antibodies and biologics that interact with growth factor precursors or latent complexes rather than the active form, potentially offering improved safety and efficacy profiles.

The company's lead program, SRK-015 (appercept), is an investigational monoclonal antibody targeting the activation of latent myostatin proproteins and is being evaluated for the treatment of spinal muscular atrophy (SMA).

Want to see what other hedge funds are holding SRRK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Scholar Rock Holding Corporation (NASDAQ:SRRK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source